Jeevan Scientific Technology Ltd

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 20 August 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Jeevan Scientific Technology Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential inflection point for investors within the healthcare services sector. Despite a recent 3.9% dip in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest improved price attractiveness relative to historical and peer benchmarks.

Jeevan Scientific Technology Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, shifting from an outstanding to a very positive financial trend. The company’s net sales surged by over 107% year-on-year, while profitability and cash reserves also showed significant gains, positioning the micro-cap healthcare services firm favourably against broader market benchmarks.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Jeevan Scientific Technology Ltd, a micro-cap player in the healthcare services sector, has seen its valuation grade upgraded from 'Sell' to 'Hold' as of 1 April 2025, reflecting a shift from an attractive to a fair valuation. Despite a challenging price-to-earnings (P/E) ratio, the stock’s recent price appreciation and relative performance against the Sensex highlight a nuanced investment case for market participants.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Jeevan Scientific Technology Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite recent market headwinds. This micro-cap healthcare services company’s price-to-earnings (P/E) ratio has plunged dramatically, signalling a potential opportunity for investors seeking value in a sector dominated by expensive peers.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Jeevan Scientific Technology Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance backdrop and evolving market dynamics.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 14 June 2026, providing investors with the latest insights into its performance and outlook.

Jeevan Scientific Technology Ltd, a micro-cap player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid mixed financial metrics and sector comparisons, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.

Jeevan Scientific Technology Ltd, a micro-cap player in the healthcare services sector, has recently experienced a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This article analyses the changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors amid recent market volatility.

Jeevan Scientific Technology Ltd has delivered a remarkable quarterly performance for March 2026, signalling a significant turnaround in its financial trajectory. The company’s latest results reveal robust revenue growth, substantial margin expansion, and a marked improvement in profitability, positioning it favourably within the healthcare services sector despite broader market headwinds.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s performance and outlook.